Gregory Botta
@gregorybotta
Followers
102
Following
43
Media
1
Statuses
47
La Jolla, San Diego
Joined March 2012
💡 With a $1 million grant from @TheVFoundation, Moores Cancer Center and @salkinstitute are changing the course of pancreatic cancer treatment. Dr. Gregory Botta is collaborating with Salk's Diana Hargreaves to improve immunotherapy treatments, identify potential biomarkers and
0
2
8
Our expert team's new publication on the Association of personalized and tumor-informed #ctDNA with patient survival outcomes in #pancreaticcancer
https://t.co/oME9GyvpDT
@UCSDCancer
academic.oup.com
Personalized, tumor-informed circulating tumor DNA (ctDNA) has been established as a biomarker for molecular residual disease across several tumor types. T
0
2
5
New #JITC case report: Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells https://t.co/Z14vOJgqRV
@gregorybotta @Kaufm020 @DrEzraCohen
0
12
41
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells | Journal for ImmunoTherapy of Cancer
jitc.bmj.com
Treatment of hematologic malignancies with patient-derived anti-CD19 chimeric antigen receptor (CAR) T-cells has demonstrated long-term remissions for patients with otherwise treatment-refractory...
0
1
2
It’s official! It is my absolute privilege to be named as the Director of the Moores Comprehensive Cancer Center at UCSD Health. I am looking forward to advancing efforts in cancer based on an approach of collaboration and excellence.
56
22
464
UCSD Faculty member, Dr. Andy Lowy delivering the MSKCC David Rubenstein Award Lecture in New York City. Prestigious award given annually for impacting the understanding, diagnosis and/t management of pancreatic cancer eradication Congratulations Dr. Lowy!
0
11
54
Day 1 at #ESMOWest2023 was a blast! 🚀 A special thank you to our fantastic speakers today for sharing their incredible expertise! @marklewismd
@gregorybotta
@Dr_RaviMadan
@marcellorotta1
@MikeLattanzi
@drkomanduri
@bvantine1
#MedEd #Oncology #MedTwitter
0
6
8
Honored to chair this outstanding conference. 💥🔥🌈🎯 Nigel and Deanna Russell at Genome Web did a great job. The speakers were so incredible that people were not looking at their iPhones. Bring together academia, industry, patients to transform precision oncology
0
5
21
Plus chat with GI medical oncologist @gregorybotta from @UCSDCancer and pancreatic cancer survivor Russ Gold @Justice_in_SD @PanCANSanDiego Register now! See you there!
1
1
3
🆕Just published🗞️ One of the 1st insights on🩸#ctDNA in patients with #AnalCancer. Of value in a number of ways & clinical settings with how the field is evolving including use of #immunotherapy➕deeper insights from sequencing🧬. @OncoAlert @OncJournal
https://t.co/zhY3X2NyYj
4
22
98
Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancers. See our @JCOPO_ASCO manuscript out today: https://t.co/63RnOisFeZ
#ctDNA
ascopubs.org
PURPOSECirculating tumor DNA (ctDNA) analyses allow for postoperative risk stratification in patients with curatively treated colon and breast cancers. Use of ctDNA in esophagogastric cancers (EGC)...
1
18
43
👇🏾🆕 @JCOPO_ASCO Delighted to be a part of this important project - one of the largest datasets providing in-depth insights & analyses into #ctDNA🩸🧬 in stomach & esophageal cancers. #STCSM #ESOCSM ➡️Sets the foundation for #MRD-driven📚. @OncoAlert 📌 https://t.co/LIYFNqNaF1
Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancers. See our @JCOPO_ASCO manuscript out today: https://t.co/63RnOisFeZ
#ctDNA
3
18
44
GI Cancers Series Part 3: Immunotherapy and Targeted Therapy in GI Cancers CURE® 12/6/22, 6:00 PM GMT -4 summer John L. Marshall @gregorybotta
@GIcancerDoc
@MarthaRaymond10
https://t.co/3y5IdWxFkV
0
1
1
ASCO 2022 on the Multicenter Phase Ib US Trial of Salvage CT041 CLDN18.2-Specific CAR T-Cell Therapy for Advanced Gastric and Pancreatic Adenocarcinoma | VuMedi https://t.co/SVcPbNhWnC via @vumedi
0
0
0
We are honored to announce that Erkki Ruoslahti has been named a #LaskerLaureate. The #LaskerAward is the most prestigious American award for biomedical research, and has been called the "American Nobel" @LaskerFDN #Lasker2022 #LaskerAward
https://t.co/6wd06zQ6CB
1
7
28
2022 Winners - Lasker Foundation: Congrats Dr Ruoslahti!
laskerfoundation.org
Richard Hynes Erkki Ruoslahti Timothy Springer Basic Award Integrins—mediators of cell-matrix and cell-cell adhesion Learn More > Yuk Ming Dennis Lo Clinical Award Noninvasive prenatal testing using...
0
0
0